Please see below for a list of search results.
The HTA was asked to provide a copy of our policy on managing and referring potential criminal breaches of Human Tissue Legislation.
The HTA was asked to provide information on the structure, number of staff, and procurement process of the HTA's finance department.
We were asked to provide information on HTA Reportable Incidents in the post-mortem sector between 2018 and 2019.
The HTA was asked to provide information on the number of lost and stolen laptops, mobile phones and tablet computers by HTA employees over the past three financial years.
All establishments licensed under the Human Tissue Act 2004 and the Quality and Safety of Organs Intended for Transplantation Regulations 2012 must review their licensing records and complete a compliance update.
The information collected will be used to:
We were asked to provide original documentation submitted as part of King's Health Partners Cancer Biobank's application for an HTA licence.
Last summer, the Health Research Authority (HRA) and the Human Tissue Authority (HTA) - in partnership with the Department for Business, Enterprise, Innovation and Skills’ (BEIS) Sciencewise programme and Ipsos MORI - published the report ‘
The HTA was asked to provide information on whether the company ‘Celixir’ had an HTA licence from 2010-13, for importing blood from patients at the Morriston Hospital and deriving mesenchymal stromal cells for research purposes.